Task: Answer the multiple choice question.
Question: Which drug exhibits a -0.570% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) COc1ccc(OC)c(NC(=O)c2cc3c(=O)n4ccccc4nc3n2C)c1
b) CC(C)NC(=O)NC(=O)COC(=O)c1ccccc1O
Answer: a. COc1ccc(OC)c(NC(=O)c2cc3c(=O)n4ccccc4nc3n2C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(OC)c(NC(=O)c2cc3c(=O)n4ccccc4nc3n2C)c1
COc1ccc(OC)c(NC(=O)c2cc3c(=O)n4ccccc4nc3n2C)c1
N-(2,5-dimethoxyphenyl)-6-methyl-2-oxo-1,6,8-triazatricyclo[7.4.0.03,7]trideca-3(7),4,8,10,12-pentaene-5-carboxamide